Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11311560
Cyclic plasmenylethanolamines
granted -
US 11311578
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11311551
Use of H3K9me3 modulation for enhancing cognitive function
granted -
US 11311574
Methods and compositions for targeted cleavage and recombination
granted -
US 11311549
Corticotropin releasing factor receptor antagonists
granted -
US 11311545
Compositions and methods for the delivery of therapeutics
granted -
US 11311526
Radiation mitigator and method of use thereof
granted -
US 11311517
Combination of small molecule CD-47 inhibitors with other anti-cancer agents
granted -
US 11311541
Treatment of GVHD
granted -
US 11311544
Treatment of congenital adrenal hyperplasia
granted -
US 11311532
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 11311485
Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer
granted -
US 11311486
Manufacturing of bupivacaine multivesicular liposomes
granted -
WO 2022081033
OPICAPONE ET LÉVODOPA POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON
granted -
US 2022119410
PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
granted -
US 11306122
Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to serotonin 2A receptor
granted -
US 11305009
Recombinant virus with diminished latency and methods of using same
granted -
US 11306135
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11304979
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11304916
Methods and compositions for the treatment of Shiga Toxicosis
granted -
US 11306288
Methods for preparing therapeutically active cells using microfluidics
granted -
US 11306132
HLA class II-restricted T cell receptors against mutated RAS
granted -
US 11306314
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 11306287
Method of generating skeletal muscle stem cells from pluripotent cells
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.